← Back
▼ SELL 10b5-1 Plan

$ Value

$303K

Shares

1,993

Price

$152

Filed

Apr 30

Insider

Name

RABINOWITZ DANIEL

Title

SEC. AND CHIEF LEGAL OFFICER

CIK

0001857843

Roles

Officer

Transaction Details

Transaction Date

2025-04-28

Code

S

Table

Non-Derivative

Ownership

Direct

Equity Swap

No

Shares After

223,674

Footnotes

The sale of shares was effected in order to satisfy tax withholding and remittance obligations in connection with the vesting of RSUs and made pursuant to a written instruction that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c) under the Exchange Act contained in the Reporting Person's Stock Unit Agreements granted on January 27, 2023 and January 26, 2024.

Filing Info

Accession No.

0001415889-25-011613

Form Type

4

Issuer CIK

0001604821

RABINOWITZ DANIEL's History

Date Ticker Type Value
2026-04-01 NTRA $60K
2026-04-01 NTRA $359K
2026-04-01 NTRA $652K
2026-04-01 NTRA $245K
2026-04-01 NTRA $391K
2026-03-10 NTRA $356K
2026-03-09 NTRA A
2026-03-06 NTRA M $110K
2026-03-06 NTRA $77K
2026-03-06 NTRA $565K

Other Insiders at NTRA (90d)

Insider Bought Sold Last
BOTHA ROELOF 2026-01-30
ROSENMAN HERM 2026-01-30
Williams Brinkley Ruth 2026-01-30
Rabinowitz Matthew
EXECUTIVE CHAIRMAN
$38.3M 2026-04-06
Sheena Jonathan $2.4M 2026-04-17
Baynes Roy D. 2026-01-30
Brophy Michael Burkes
CHIEF FINANCIAL OFFICER
$2.9M 2026-03-10
Marcus Gail Boxer 2026-01-30
Chapman Steven Leonard
CEO AND PRESIDENT
$24.1M 2026-03-10
Bertagnolli Monica 2026-01-30
Chapman Rowan E $23K 2026-03-13
RABINOWITZ DANIEL
SEC. AND CHIEF LEGAL OFFICER
$4.5M 2026-04-01
Moshkevich Solomon
PRESIDENT, CLINICALDIAGNOSTICS
$3.0M 2026-04-01
Fesko John
PRESIDENT, CHIEF BUS. OFFICER
$1.4M 2026-03-10